Items where Division is "Current Faculties > Faculty of Medicine > School of Healthcare, Enterprise and Innovation > SHTAC
School of Healthcare, Enterprise and Innovation > SHTAC" and Year is 2024
 | Up a level |
Number of items: 12.
Using cure modelling for cost effectiveness in the NICE technology appraisal of Polatuzumab Vedotin in combination for untreated diffuse large B cell lymphoma: an external assessment group perspective - Keith Cooper, Emma Maund, Marcia Tomie Takahashi and Jonathan Shepherd
Type: Review
| 2024
Enfortumab vedotin with pembrolizumab for first-line treatment of unresectable or metastatic urothelial cancer who are eligible for platinum-containing chemotherapy [ID6332]: a single technology appraisal - Emma Maund, Fay Chinnery, Keith Cooper and Jonathan Shepherd
Type: Monograph
| 2024
| Southampton Health Technology Assessments Centre
Tarlatamab for previously treated advanced small-cell lung cancer: a single technology appraisal - Karen Pickett, Asyl Hawa, Keith Cooper, Jo Picot and David Alexander Scott
Type: Monograph
| 2024
| Southampton Health Technology Assessments Centre
Lebrikizumab for treating moderate to severe atopic dermatitis in people 12 years and over: a single technology appraisal - Karen Pickett, Ines Ribeiro, Jo Picot, Keith Cooper and David Alexander Scott
Type: Monograph
| 2024
| Southampton Health Technology Assessments Centre
Spesolimab for treating generalised pustular psoriasis flares: a single technology appraisal - Ines Ribeiro, Lois Woods, Asyl Hawa and Jo Picot
Type: Monograph
| 2024
| Southampton Health Technology Assessments Centre
Molnupiravir for COVID-19 (ID6340).: a single technology appraisal - Ines Ribeiro, Lois Woods, Neelam Kalita, David Alexander Scott and Geoff Frampton
Type: Monograph
| 2024
| National Institute for Health Research
An economic evaluation of local anaesthetic transperineal biopsy in people with suspected prostate cancer - Ines Ribeiro, Lois Woods, Emma Maund, David Alexander Scott, Joanne Lord, Jo Picot and Jonathan Shepherd
Type: Conference or Workshop Item
| 2024
| Item not available on this server.
Bevacizumab gamma for treating wet age-related macular degeneration: a cost-comparison technology appraisal - Jonathan Shepherd, Fay Chinnery, Emma Maund, David Alexander Scott and Joanne Lord
Type: Monograph
| 2024
| Southampton Health Technology Assessments Centre
Transperineal biopsy devices in people with suspected prostate cancer - a systematic review and economic evaluation - Ines Souto-Ribeiro, Lois Woods, Emma Maund, David Alexander Scott, Joanne Lord, Joanna Picot and Jonathan Shepherd
Type: Article
| 2024
Relugolix for treating hormone-sensitive prostate cancer: a single technology appraisal - Marcia Takahashi, Emma Maund, Asyl Hawa, David Alexander Scott, Jonathan Shepherd and Joanne Lord
Type: Monograph
| 2024
| Southampton Health Technology Assessments Centre
Health care professional barriers and facilitators to discontinuing antidepressant use: A systematic review and thematic synthesis - Ellen Van Leeuwen, Emma Maund, Catherine Woods, Hannah Bowers, Thierry Christiaens and Tony Kendrick
Type: Review
| 2024
Self-protective behaviors of Thai village health volunteers in community engagement during a COVID-19 outbreak: interpretation using the health belief model - Paleeratana Wongrith, Phuwasin Buakate, Lateefah Doylee, Naseeyah Phonla, Omid Dadras and Geoff Frampton
Type: Article
| 2024